APA (7th ed.) Citation

Alexander, P. M., Caudell, D. L., Kucera, G. L., Pladna, K. M., & Pardee, T. S. The novel phospholipid mimetic KPC34 is highly active against preclinical models of Philadelphia chromosome positive acute lymphoblastic leukemia. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Alexander, Peter M., David L. Caudell, Gregory L. Kucera, Kristin M. Pladna, and Timothy S. Pardee. The Novel Phospholipid Mimetic KPC34 Is Highly Active Against Preclinical Models of Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia. Public Library of Science (PLoS).

MLA (9th ed.) Citation

Alexander, Peter M., et al. The Novel Phospholipid Mimetic KPC34 Is Highly Active Against Preclinical Models of Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia. Public Library of Science (PLoS).